Auris, nasus, larynx, vol.48, no.5, pp.999-1006, 2021 (SCI-Expanded)
Objective: Skull baseosteomyelitis (SBO) is a rare phenomenon that typically occurs in diabetic or immunocompromised patients, causing significant morbidity and mortality. This study aimed to analyze a single institution's treatment results in SBO patients and propose anew integrated clinicoradiological classification system.